Drugs / iPS-NCS
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT03815071 | Feb 2019 → Feb 2020 | Parkinson disease | Allife Medical Science and Technology Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | iPS-NCS | “This is a single center, single arm and open-label study to investigate the safety and efficacy of iPS-NCS with Parkinson's Disease” NCT03815071 ↗ |